We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$6.49B
AUM Growth
-$91.2M
Cap. Flow
+$25.2M
Cap. Flow %
0.39%
Top 10 Hldgs %
18.45%
Holding
1,603
New
478
Increased
239
Reduced
260
Closed
489

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.9%
2 Communication Services 3.18%
3 Healthcare 3.02%
4 Financials 2.03%
5 Technology 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIVN icon
76
CALL
LivaNova
LIVN
$4.29B
$18.4M 0.28%
336,400
+177,300
+111% +$10.1M
BSX icon
77
CALL
Boston Scientific
BSX
$63.1B
$18M 0.28%
+234,000
New +$17.1M
HUBS icon
78
CALL
HubSpot
HUBS
$11.4B
$17.7M 0.27%
+30,000
New +$18.4M
WES icon
79
CALL
Western Midstream Partners
WES
$19.5B
$17.6M 0.27%
443,400
-75,000
-14% -$2.76M
MDB icon
80
PUT
MongoDB
MDB
$31.7B
$17.5M 0.27%
70,000
HASI icon
81
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.78B
$17M 0.26%
574,000
+216,500
+61% +$6.33M
ASPN icon
82
PUT
Aspen Aerogels
ASPN
$426M
$16.6M 0.26%
697,300
+107,100
+18% +$2.51M
APLS
83
DELISTED
Apellis Pharmaceuticals
APLS
$16.5M 0.25%
430,000
+399,000
+1,287% +$18.1M
ARGX icon
84
PUT
argenx
ARGX
$62.3B
$16.3M 0.25%
+38,000
New +$14.5M
SRPT icon
85
PUT
Sarepta Therapeutics
SRPT
$2.18B
$16.3M 0.25%
102,900
+23,100
+29% +$2.97M
PEGA icon
86
CALL
Pegasystems
PEGA
$5.93B
$15.8M 0.24%
522,400
+102,200
+24% +$3.06M
IONS icon
87
CALL
Ionis Pharmaceuticals
IONS
$7.77B
$15.7M 0.24%
+329,300
New +$13.5M
PAR icon
88
PAR Technology
PAR
$661M
$15.4M 0.24%
326,600
-45,400
-12% -$2.01M
APD icon
89
CALL
Air Products & Chemicals
APD
$63.7B
$15.2M 0.23%
+58,800
New +$14.9M
CERE
90
CALL
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$15.1M 0.23%
370,000
+100,000
+37% +$4.16M
KBR icon
91
CALL
KBR
KBR
$4.63B
$14.8M 0.23%
231,000
+216,000
+1,440% +$14M
FNV icon
92
CALL
Franco-Nevada
FNV
$51.4B
$14.8M 0.23%
124,800
+58,200
+87% +$7.07M
RUN icon
93
PUT
Sunrun
RUN
$2.1B
$14.8M 0.23%
1,246,300
+249,000
+25% +$3.05M
DXCM icon
94
CALL
DexCom
DXCM
$33.2B
$14.7M 0.23%
130,000
+100,000
+333% +$12.6M
REGN icon
95
PUT
Regeneron Pharmaceuticals
REGN
$81.3B
$14.7M 0.23%
+14,000
New +$13.6M
UBER icon
96
CALL
Uber
UBER
$145B
$14.5M 0.22%
200,000
+150,000
+300% +$10.4M
CFLT
97
CALL
DELISTED
Confluent
CFLT
$14.5M 0.22%
490,800
-416,000
-46% -$12M
KRYS icon
98
CALL
Krystal Biotech
KRYS
$10B
$14.5M 0.22%
78,700
+56,300
+251% +$9.45M
PCRX icon
99
PUT
Pacira BioSciences
PCRX
$976M
$14.3M 0.22%
500,000
+378,000
+310% +$10.8M
PARA
100
PUT
DELISTED
Paramount Global Class B
PARA
$14.2M 0.22%
+1,370,900
New +$16.1M

Similar funds

Caption Management's Q2 2024 Portfolio in Review

As of Q2 2024, Caption Management held 1,603 positions worth $6.49B, down 1.4% from $6.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management's Q2 2024 filing shows 478 new, 239 increased, 260 reduced and 489 closed positions. Its largest new stake was Alphabet (Google) Class C: 233,700 shares worth $42.9M. The largest sale was Meta Platforms (Facebook), an estimated $25.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, down from 88% a quarter earlier, followed by Communication Services and Healthcare.

  • Caption Management's largest Q2 2024 buy was Alphabet (Google) Class C: 233,700 shares worth $42.9M.
  • Caption Management added most to First Solar in Q2 2024, an estimated $18.5M increase.
  • Caption Management's biggest Q2 2024 reduction was Intra-Cellular Therapies Inc., cutting an estimated $18.5M.
  • Caption Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $25.5M.
  • Caption Management's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2024.
  • Caption Management opened 478 new positions and closed 489 in Q2 2024.
  • Caption Management's portfolio value fell 1.4% quarter-over-quarter to $6.49B.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.